Katy Beckermann/medschool.vanderbilt.edu
Aug 25, 2025, 12:13
Katy Beckermann: Privileged to Moderate World Conference On GU Cancers Panel of Amazing Colleagues
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post on X by Karine Tawagi, Assistant Professor of Clinical Medicine and Fellowship Program Director at the University of Illinois Chicago, adding:
“What a privilege to moderate this panel of amazing colleagues. We discussed the many facets of patient care: novel agents, assessing frailty, communication skills, multidisciplinary care, rapid drug approvals, and building nimble care pathways.”
Quoting Karine Tawagi’s post:
“All-star panel World Conference On Genitourinary Cancers day 2”
- precision oncology – Ulka Vaishampayan
- 600 men/yr still die from testicular CA – emerging target Claudin-6 in refractory germ cell CA – Elisabeth Heath
- frailty G8 tools – Stephanie Berg
- pall care tools, pathways, multiD communication.”
More posts featuring Katy Beckermann and Karine Tawagi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 11:07
Aug 25, 2025, 09:45
Aug 25, 2025, 09:09